{
    "root": "8d9390f9-1029-4990-a9a8-3e99a553a38c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "nebivolol",
    "value": "20250317",
    "ingredients": [
        {
            "name": "NEBIVOLOL HYDROCHLORIDE",
            "code": "JGS34J7L9I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_132912"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "FD&C BLUE NO. 2 ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "FD&C YELLOW NO. 6 ALUMINUM LAKE",
            "code": "GYP6Z2JR6Q"
        },
        {
            "name": "D&C RED NO. 27",
            "code": "2LRS185U6K"
        }
    ],
    "indications": {
        "text": "nebivolol beta-adrenergic blocking agent indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 5.5 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "taken without food . individualize needs patient monitor up-titration . ( 2 ) \u2022 hypertension : patients start 5 mg daily . dose increased 2-week intervals 40 mg. ( 2 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "nebivolol tablets available tablets oral containing nebivolol hydrochloride equivalent 2.5 , 5 , 10 , 20 mg nebivolol . nebivolol tablets mosaic appearance , round , biconvex , uncoated , unscored , differentiated color plain one side debossed number 53 , 1354 , 1355 1356 side 2.5 , 5 , 10 20 mg tablets , respectively . nebivolol tablets supplied following strengths package configurations : 2.5 mg tablets light blue colored mosaic appearance , round , biconvex uncoated tablets , debossed `` 53 `` one side plain side . cartons 30 tablets ( 10 tablets blister pack x 3 ) , ndc 0904-7225-04 5 mg tablets beige colored mosaic appearance , round , biconvex uncoated tablets , debossed `` 1354 `` one side plain side . cartons 30 tablets ( 10 tablets blister pack x 3 ) , ndc 0904-7189-04 10 mg tablets pinkish purple colored mosaic appearance , round , biconvex uncoated tablets , debossed `` 1355 `` one side plain side . cartons 30 tablets ( 10 tablets blister pack x 3 ) , ndc 0904-7190-04 20 mg tablets light blue colored mosaic appearance , round , biconvex uncoated tablets , debossed `` 1356 `` one side plain side . cartons 30 tablets ( 10 tablets blister pack x 3 ) , ndc 0904-7226-04 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) , excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "nebivolol contraindicated following conditions : \u2022 severe bradycardia \u2022heart block greater first degree \u2022patients cardiogenic shock \u2022decompensated cardiac failure \u2022sick sinus syndrome ( unless permanent pacemaker place ) \u2022patients severe hepatic impairment ( child-pugh > b ) \u2022patients hypersensitive component product .",
    "indications_original": "Nebivolol is a beta-adrenergic blocking agent indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 5.5 )",
    "contraindications_original": "Can be taken with and without food. Individualize to the needs of the patient and monitor during up-titration. ( 2 ) \u2022 Hypertension: Most patients start at 5 mg once daily. Dose can be increased at 2-week intervals up to 40 mg. ( 2 )",
    "warningsAndPrecautions_original": "Nebivolol tablets are available as tablets for oral administration containing nebivolol hydrochloride equivalent to 2.5, 5, 10, and 20 mg of nebivolol.\n                  Nebivolol tablets have a mosaic appearance, are round, biconvex, uncoated, unscored, differentiated by color and are plain on one side and debossed with the number 53, 1354, 1355 or 1356 on the other side for the 2.5, 5, 10 and 20 mg tablets, respectively. Nebivolol tablets are supplied in the following strengths and package configurations:\n                  2.5 mg tablets are light blue colored with mosaic appearance, round, biconvex uncoated tablets, debossed with \"53\" on one side and plain on other side.\n                  Cartons of 30 tablets (10 tablets each blister pack x 3), NDC 0904-7225-04\n                  5 mg tablets are beige colored with mosaic appearance, round, biconvex uncoated tablets, debossed with \"1354\" on one side and plain on other side.\n                  Cartons of 30 tablets (10 tablets each blister pack x 3), NDC 0904-7189-04\n                  10 mg tablets are pinkish purple colored with mosaic appearance, round, biconvex uncoated tablets, debossed with \"1355\" on one side and plain on other side.\n                  Cartons of 30 tablets (10 tablets each blister pack x 3), NDC 0904-7190-04\n                  20 mg tablets are light blue colored with mosaic appearance, round, biconvex uncoated tablets, debossed with \"1356\" on one side and plain on other side.\n                  Cartons of 30 tablets (10 tablets each blister pack x 3), NDC 0904-7226-04\n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F), excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP for Controlled Room Temperature].\n                     \n                  \n                  Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "Nebivolol is contraindicated in the following conditions:\n                  \n                     \n                        \u2022\n                        Severe bradycardia\n                     \n                     \n                        \u2022Heart block greater than first degree\n                     \n                        \u2022Patients with cardiogenic shock\n                     \n                        \u2022Decompensated cardiac failure\n                     \n                        \u2022Sick sinus syndrome (unless a permanent pacemaker is in place)\n                     \n                        \u2022Patients with severe hepatic impairment (Child-Pugh >B)\n                     \n                        \u2022Patients who are hypersensitive to any component of this product.",
    "drug": [
        {
            "name": "nebivolol",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_64022"
        }
    ]
}